Press release
Diabetic Macular Edema Market Drivers and Challenges Through 2031 Including Rising Treatment Costs and Limited Access in Developing Regions
Diabetic Macular Edema Market
According to the latest research by InsightAce Analytic, the Diabetic Macular Edema Market is valued at US$ 3.95 billion in 2023, and it is expected to reach US$ 4.56 billion by 2031, with a CAGR of 1.9% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2895
Diabetic Macular Edema (DME) is a progressive ocular condition resulting from damage to the retina's microvasculature, leading to fluid accumulation and swelling in the macula. Often asymptomatic in its initial stages, DME poses a significant threat to vision if left untreated. With growing global concerns regarding diabetes-related complications, the demand for effective DME treatments is projected to increase over the forecast period.
The market is expected to experience robust growth, driven by the rising adoption of established therapies such as aflibercept, bevacizumab, and ranibizumab. These therapeutics are anticipated to play a critical role in the expansion of the global DME market. Furthermore, increasing investments in research and development, supported by rising disposable incomes, are creating favorable conditions for market advancement.
Key industry stakeholders are actively investing in the development of innovative treatment options, enhancing the market's revenue potential. In addition, government-led initiatives aimed at improving treatment accessibility and raising awareness of DME and its management are expected to further support market expansion and strengthen the industry landscape.
List of Prominent Players in the Diabetic Macular Edema Market:
• Novartis AG
• Bayer AG
• Allergen Plc.
• F. Hoffmann-La Roche Ltd.
• Alimera Sciences Inc.
• Valeant Pharmaceuticals International, Inc.
• KalVista Pharmaceuticals
• Genentech
• Oxurion
• Ocugen, Inc
• Regeneron Pharmaceuticals, Inc.
• Clearside Biomedical
• Daiichi Sankyo
• Arctic Vision
• Chugai Pharmaceutical Co., Ltd.
• Sanofi
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Lupin
• Allergan
• Merck & Co., Inc.
• Pfizer Inc.
• GlaxoSmithKline plc
• IRIDEX Corporation
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Drivers:
The growing global prevalence of diabetes, coupled with continuous advancements in treatment modalities, is expected to be a primary driver of growth in the Diabetic Macular Edema (DME) market. Increasing demand for effective therapeutic interventions among diabetic patients is anticipated to significantly contribute to overall market revenue. Additionally, the expansion of research and development initiatives aimed at enhancing the efficacy and accessibility of DME treatments is projected to further accelerate market growth.
Challenges:
Despite the positive growth outlook, the DME market faces notable challenges. A lack of awareness regarding the condition, combined with a shortage of qualified healthcare professionals-particularly in developing regions-continues to hinder widespread adoption of DME therapies. Moreover, the high cost of treatment remains a key barrier for patients and healthcare systems alike. The COVID-19 pandemic has also adversely impacted the market by disrupting global supply chains, reducing patient access to care, and causing temporary shutdowns of manufacturing facilities due to lockdowns and public health restrictions.
Regional Trends:
North America is anticipated to lead the global DME market in terms of revenue and is forecasted to register a strong compound annual growth rate (CAGR) throughout the projection period. This dominance is attributed to a rising diabetic population, robust R&D activities, and the presence of leading market players. Europe also holds a significant market share, supported by its advanced healthcare infrastructure and increased adoption of innovative treatment solutions. Strategic collaborations among key stakeholders and the implementation of forward-looking business initiatives are expected to further enhance regional market penetration and create promising opportunities for sustained growth.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2895
Segmentation of Diabetic Macular Edema Market-
By Drug Type-
• Anti-VEGF
o Ranibizumab (Lucentis)
o Aflibercept (Eylea)
• Corticosteroid Therapies
o Dexamethasone (Ozurdex)
o Fluocinolone Acetonide (Iluvien)
• Others
By Form-
• Intravitreal Injections
• Intravitreal Implants
By Distribution Channel-
• Hospitals
• Specialty Clinics
• Mail Order Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Macular Edema Market Drivers and Challenges Through 2031 Including Rising Treatment Costs and Limited Access in Developing Regions here
News-ID: 3962483 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
RNAi Pesticides Market Report on the Untapped Growth Opportunities in the Indust …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034."
The RNAi…
Rice Bran Wax Lubricant Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million…
Returnable Plastic Crate Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Returnable Plastic Crate Market - (By Capacity (Less than 10 kg, 10 kg to 20 kg, 21 to 35 kg, 36 to 50 kg, Above 50 kg), By Product Type (Stackable, Nestable, Collapsible), By Material (High-Density Polyethylene (HDPE), Polypropylene (P.P.), Others), By Application (Agriculture, Grocery, Dairy, Bakery, Seafood & Meat, Others)), Trends, Industry Competition…
Respiratory Disease Genetic Testing Market Exclusive Report on the Latest Revenu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Respiratory Disease Genetic Testing Market- (By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type (COPD (Alpha-1-antitrypsin (AAT), Cystic Fibrosis (CF), Diffuse Lung Disease/Surfactant Dysfunction (RHD (Respiratory Distress Syndrome), PPHN (Persistent Pulmonary Hypertension of the Newborn)), Interstitial lung disease, Pulmonary Arterial Hypertension, Pulmonary Hypoplasia, Primary Ciliary Dyskinesia, Other Diseases (BPD)), By Offerings (PCR, NGS…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
